Skip to content
10-K/A

Annual Report

BIOREGENX, INC. BRGX

0001683168-25-002623

← back to feed
Filed
Apr 16, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 31, 2025 956.99M sh
Shares Diluted restated FY 2024 · Dec 31, 2024 939.51M sh
Shares Diluted restated FY 2024 · Dec 31, 2023 639.78M sh
Capex FY 2024 · Dec 31, 2024 $189.39K
Capex FY 2024 · Dec 31, 2023 $0
Operating Cash Flow FY 2024 · Dec 31, 2024 −$324.15K
Operating Cash Flow restated FY 2024 · Dec 31, 2023 −$1.52M
Long Term Debt FY 2024 · Dec 31, 2024 $254.61K
Short Term Debt FY 2024 · Dec 31, 2024 $883.27K
Cash And Equivalents FY 2024 · Dec 31, 2024 $58.4K
Cash And Equivalents FY 2024 · Dec 31, 2023 $125.4K
Stockholders Equity FY 2024 · Dec 31, 2024 −$3.38M
Stockholders Equity restated FY 2024 · Dec 31, 2023 −$2.07M
Stockholders Equity restated FY 2024 · Dec 31, 2022 −$2.53M
Current Liabilities FY 2024 · Dec 31, 2024 $3.63M
Current Liabilities restated FY 2024 · Dec 31, 2023 $2.79M
Total Liabilities FY 2024 · Dec 31, 2024 $3.89M
Total Liabilities restated FY 2024 · Dec 31, 2023 $2.94M
Current Assets FY 2024 · Dec 31, 2024 $307.8K
Current Assets restated FY 2024 · Dec 31, 2023 $652.66K
Total Assets FY 2024 · Dec 31, 2024 $508.54K
Total Assets restated FY 2024 · Dec 31, 2023 $865.75K
Eps Diluted restated FY 2024 · Dec 31, 2024 −$0.02
Eps Diluted restated FY 2024 · Dec 31, 2023 −$0.01
Eps Basic restated FY 2024 · Dec 31, 2024 −$0.02
Eps Basic restated FY 2024 · Dec 31, 2023 −$0.01
Sga Expense FY 2024 · Dec 31, 2024 $5.85M
Sga Expense FY 2024 · Dec 31, 2023 $5.23M
Rd Expense FY 2024 · Dec 31, 2024 $0
Rd Expense FY 2024 · Dec 31, 2023 $257.72K
Net Income FY 2024 · Dec 31, 2024 −$23.05M
Net Income restated FY 2024 · Dec 31, 2023 −$3.6M
Operating Income FY 2024 · Dec 31, 2024 −$22.76M
Operating Income restated FY 2024 · Dec 31, 2023 −$3.41M
Gross Profit FY 2024 · Dec 31, 2024 $1.66M
Gross Profit FY 2024 · Dec 31, 2023 $2.31M
Cost Of Revenue FY 2024 · Dec 31, 2024 $681.69K
Cost Of Revenue FY 2024 · Dec 31, 2023 $1.1M
Revenue FY 2024 · Dec 31, 2024 $2.34M
Revenue restated FY 2024 · Dec 31, 2023 $3.41M